Ordinary Adjustment | Solactive Global Health Services & Technology EMEA | Effective Date 21st January 2025
Solactive Global Health Services & Technology EMEA:
In the ordinary adjustment, the following composition will be implemented effective open 21st January 2025:
| AL HAMMADI CO FOR DEVELOPMEN |
| ALCON INC |
| ARGENX SE |
| ASTRAZENECA PLC |
| BIOMERIEUX |
| COLOPLAST AS CLASS B |
| DIASORIN SPA |
| DR SULAIMAN AL HABIB MEDICAL SERVICES GROUP CO |
| ESSILORLUXOTTICA |
| FRESENIUS MEDICAL CARE AG & CO KGAA |
| FRESENIUS SE & CO KGAA |
| GALDERMA GROUP AG |
| GENMAB A/S |
| GETINGE AB CLASS B |
| GSK PLC |
| HIKMA PHARMACEUTICALS PLC |
| INTERNATIONAL HOLDINGS CO PJSC |
| IPSEN SA |
| LONZA GROUP AG |
| MERCK KGAA |
| MOUWASAT MEDICAL |
| NOVARTIS AG |
| ORION OYJ CLASS B |
| PURE HEALTH HOLDING PJSC ORD |
| RECORDATI SPA |
| ROCHE HOLDING AG |
| SANDOZ GROUP AG |
| SANOFI SA |
| SAUDI PHARMACEUTICAL INDUSTR |
| SIEGFRIED HOLDING AG-REG |
| SIEMENS HEALTHINEERS AG |
| SONOVA HOLDING AG |
| UCB SA |